Predicta Biosciences

View 5 free companies with a free account

Get full access to valuations, team members, funding history, and investor details.

Investors

Venture capital firms, private equity investors, and strategic partners

InvestorType
American Cancer Society
N/A
Binney Street Capital
N/A
BrightEdge
Venture Capital
Engine Ventures
Venture Capital
Illumina Ventures
Venture Capital

+7 More Investors Available

Sign in to see the complete investor list

Types of Investors
Predicta Biosciences has attracted various types of institutional and strategic investors

Common Investor Types

  • Venture Capital Firms: Early-stage and growth equity investors
  • Private Equity: Later-stage institutional investors
  • Strategic Investors: Corporations in related industries
  • Angel Investors: High-net-worth individuals
  • Family Offices: Private wealth management firms

What Investors Provide

  • Capital for growth and expansion
  • Strategic guidance and expertise
  • Industry connections and partnerships
  • Market validation and credibility
  • Board representation and governance

Who Invested in Predicta Biosciences?

Predicta Biosciences has attracted investment from 12+ venture capital firms, private equity investors, and strategic partners across 0 funding rounds. These investors have provided a total of $29.2M in capital to fuel the company's growth.

Why Do Investors Fund Predicta Biosciences?

Investors are attracted to Predicta Biosciences due to the company's strong market position, growth potential, and proven business model. The company's current valuation of $49M reflects investor confidence in its ability to generate returns through continued growth, potential IPO, or strategic acquisition.

Types of Predicta Biosciences Investors

Predicta Biosciences investors typically include a mix of venture capital firms providing growth capital, private equity firms for later-stage funding, strategic corporate investors from related industries, and high-net-worth angel investors. Each investor type brings unique value beyond capital, including industry expertise, strategic partnerships, and operational guidance.

Investor FAQs

How many investors does Predicta Biosciences have?

Predicta Biosciences has had 12+ investors participate across its funding rounds. This includes venture capital firms, private equity investors, strategic partners, and angel investors.

Who are the lead investors in Predicta Biosciences?

Lead investors typically invest the largest amounts and often take board seats. For detailed information about Predicta Biosciences's lead investors and cap table structure, please contact our team.

Can I become an investor in Predicta Biosciences?

Accredited investors can purchase Predicta Biosciences shares on the secondary market through Premier Alternatives. This provides an opportunity to invest in the company before a potential IPO or acquisition event.